Antibody Response to the BNT162b2 mRNA COVID-19 Vaccine in Subjects with Prior SARS-CoV-2 Infection

Antibody Response to the BNT162b2 mRNA COVID-19 Vaccine in Subjects with Prior SARS-CoV-2 Infection

Although antibody levels progressively decrease following SARS-CoV-2 infection, the immune memory persists for months.<b> </b>Thus, individuals who naturally contracted SARS-CoV-2 are expected to develop a more rapid and sustained response to COVID-19 vaccines than naïve individuals.<...

Full description

Bibliographic Details
Main Authors: Federico Gobbi, Dora Buonfrate, Lucia Moro, Paola Rodari, Chiara Piubelli, Sara Caldrer, Silvia Riccetti, Alessandro Sinigaglia, Luisa Barzon
Format: Article
Language:English
Published: MDPI AG 2021-03-01
Series:Viruses
Subjects:
COVID-19 vaccine
neutralizing antibody
anti-spike RBD IgG antibody
BNT162b2 vaccine
SARS-CoV-2
immune response
Online Access:https://www.mdpi.com/1999-4915/13/3/422

Internet

https://www.mdpi.com/1999-4915/13/3/422

Similar Items